Inhibition of hepatic microsomal triglyceride transfer protein – a novel therapeutic option for treatment of homozygous familial hypercholesterolemia

References

• UsifoELeighSEWhittallRALow-density lipoprotein receptor gene familial hypercholesterolemia variant database: update and pathological assessmentAnn Hum Genet201276538740122881376
   PubMed Web of Science ®Google Scholar
• BrownMSKovanenPTGoldsteinJLRegulation of plasma cholesterol by lipoprotein receptorsScience198121244956286356261329
   PubMed Web of Science ®Google Scholar
• BrownMSKovanenPTGoldsteinJLPrenatal diagnosis of homozygous familial hypercholesterolaemia. Expression of a genetic receptor disease in uteroLancet19781806352652976071
   PubMed Web of Science ®Google Scholar
• GoldsteinJLHobbsHHBrownMSFamilial hypercholesterolemiaScriverCRBeaudetALSlyWSThe Metabolic and Molecular Bases of Inherited Disease8th edNew YorkMcGraw-Hill200128632913
   Google Scholar
• NordestgaardBGChapmanMJHumphriesSEEuropean Atherosclerosis Society Consensus PanelFamilial hypercholesterolemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis SocietyEur Heart J201334453478a3490a23956253
   PubMed Web of Science ®Google Scholar
• LeitersdorfEVan der WesthuyzenDRCoetzeeGAHobbsHHTwo common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in AfrikanersJ Clin Invest19898439549612569482
   PubMed Web of Science ®Google Scholar
• SeftelHCBakerSGSandlerMPA host of hypercholesterolaemic homozygotes in South AfricaBr Med J198028162416336367437743
   PubMed Web of Science ®Google Scholar
• LehrmanMASchneiderWJBrownMSThe Lebanese allele at the low density lipoprotein receptor locus. Nonsense mutation produces truncated receptor that is retained in endoplasmic reticulumJ Biol Chem198726214014103025214
   PubMed Web of Science ®Google Scholar
• FahedACSafaRMHaddadFFHomozygous familial hypercholesterolemia in Lebanon: a genotype/phenotype correlationMol Genet Metab2011102218118821145767
   PubMed Web of Science ®Google Scholar
• MoorjaniSRoyMGagnéCHomozygous familial hypercholesterolemia among French Canadians in Québec ProvinceArteriosclerosis1989922112162923577
   PubMedGoogle Scholar
• HaitasBBakerSGMeyerTEJoffeBISeftelHCNatural history and cardiac manifestations of homozygous familial hypercholesterolaemiaQ J Med1990762797317402217676
   PubMedGoogle Scholar
• BertoliniSCassanelliSGarutiMAnalysis of LDL receptor gene mutations in Italian patients with homozygous familial hypercholesterolemiaArterioscler Thromb Vasc Biol19991924084189974426
   PubMed Web of Science ®Google Scholar
• RaalFJSantosRDBlomDJMipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolemia: a randomised, double-blind, placebo-controlled trialLancet20103759719998100620227758
   PubMed Web of Science ®Google Scholar
• RaalFJSantosRDHomozygous familial hypercholesterolemia: current perspectives on diagnosis and treatmentAtherosclerosis2012223226226822398274
   PubMed Web of Science ®Google Scholar
• MabuchiHNoharaANoguchiTHokuriku FH Study GroupMolecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of JapanAtherosclerosis2011214240440721146822
   PubMed Web of Science ®Google Scholar
• NaoumovaRPThompsonGRSoutarAKCurrent management of severe homozygous hypercholesterolaemiasCurr Opin Lipidol200415441342215243214
   PubMed Web of Science ®Google Scholar
• KraftHGLingenhelARaalFJHoheneggerMUtermannGLipoprotein(a) in homozygous familial hypercholesterolemiaArterioscler Thromb Vasc Biol200020252252810669652
   PubMed Web of Science ®Google Scholar
• HolmesDTSchickBAHumphriesKHFrohlichJLipoprotein(a) is an independent risk factor for cardiovascular disease in heterozygous familial hypercholesterolemiaClin Chem200551112067207316141286
   PubMed Web of Science ®Google Scholar
• RaalFJPilscherGJIllingworthDRExpanded-dose simvastatin is effective in homozygous familial hypercholesterolaemiaAtherosclerosis199713522492569430375
   PubMed Web of Science ®Google Scholar
• InnerarityTLWeisgraberKHArnoldKSFamilial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor bindingProc Natl Acad Sci U S A19878419691969233477815
   PubMed Web of Science ®Google Scholar
• AbifadelMVarretMRabèsJPMutations in PCSK9 cause autosomal dominant hypercholesterolemiaNat Genet200334215415612730697
   PubMed Web of Science ®Google Scholar
• GarciaCKWilundKArcaMAutosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor proteinScience200129255201394139811326085
   PubMed Web of Science ®Google Scholar
• KästnerMHöherMVogtMLangDMyokardinfarkt bei einem 7jährigen Kind mit familiärer Hypercholesterinämie. [Myocardial infarction in a seven-and-a-half year old child with familial hypercholesterolemia]Monatsschr Kinderheilkunde19981461211761180 German
   Google Scholar
• WidhalmKBinderCBKreisslASudden death in a 4-year-old boy: a near-complete occlusion of the coronary artery caused by an aggressive lipoprotein receptor mutation (W556R) in homozygous familial hypercholesterolemiaJ Pediatr2011158116720659736
   PubMed Web of Science ®Google Scholar
• SantosRDMinameMHMartinezLRNon-invasive detection of aortic and coronary atherosclerosis in homozygous familial hypercholesterolemia by 64 slice multi-detector row computed tomography angiographyAtherosclerosis2008197291091517884061
   PubMed Web of Science ®Google Scholar
• KawaguchiAYutaniCYamamotoAHypercholesterolemic valvulopathy: an aspect of malignant atherosclerosisTher Apher Dial20037443944312887729
   PubMed Web of Science ®Google Scholar
• UauyRVegaGLGrundySMBilheimerDMLovastatin therapy in receptor-negative homozygous familial hypercholesterolaemia: lack of effect on low-density lipoprotein concentrations or turnoverJ Pediatr198811323873923397806
   PubMed Web of Science ®Google Scholar
• ThompsonGRFordJJenkisonMTraynerIEfficacy of mevinolin as adjuvant therapy for refractory familial hypercholesterolemiaQ J Med1986602328038113640503
   PubMedGoogle Scholar
• RaalFJPappuASIllingworthDRInhibition of cholesterol synthesis by atorvastatin in homozygous familial hypercholesterolaemiaAtherosclerosis2000150242142810856535
   PubMed Web of Science ®Google Scholar
• MaraisADRaalFJSteinEAA dose-titration and comparative study of rosuvastatin and atorvastatin in patients with homozygous familial hypercholesterolaemiaAtherosclerosis2008197140040617727860
   PubMed Web of Science ®Google Scholar
• MaraisADFirthJCNaoumovaRPThompsonGRThe role of HMG-CoA reductase inhibitors in homozygous familial hypercholesterolaemiaGottoAMJrPaolettiRSmithLCCatapanoALJacksonASDrugs Affecting Lipid Metabolism: Risk Factors and Future DirectionsNew YorkSpringer1996181186
   Google Scholar
• RaalFJPilcherGJPanzVRReduction in mortality in subjects with homozygous familial hypercholestrolemia associated with advances in lipid-lowering therapyCirculation2011124202202220721986285
   PubMed Web of Science ®Google Scholar
• KolanskyDMCuchelMClarkBJLongitudinal evaluation and assessment of cardiovascular disease in patients with homozygous familial hypercholesterolemiaAm J Cardiol2008102111438144319026292
   PubMed Web of Science ®Google Scholar
• KroonAAvan’t HofMADemackerPNStalenhoefAFThe rebound of lipoproteins after LFL-apheresis. Kinetics and estimation of mean lipoprotein levelsAtherosclerosis2000152251952610998482
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical ExcellenceIdentification and Management of Familial Hypercholesterolaemia. NICE Clinical Guideline 71LondonNational Institute for Health and Clinical Excellence2008 Available from: http://www.nice.org.uk/nicemedia/pdf/CG071NICEGuideline.pdfAccessed October 20, 2013
   Google Scholar
• GræsdalABogsrudMPHolvenKBApheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemiaJ Clin Lipidol20126433133922836070
   PubMed Web of Science ®Google Scholar
• Harada-ShibaMAraisHOikawaSGuidelines for the management of familial hypercholesterolemiaJ Atheroscler Thromb201219121043106023095242
   PubMed Web of Science ®Google Scholar
• SchwartzJWintersJLPadmanabhanAGuidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issueJ Clin Apher201328314528423868759
   PubMed Web of Science ®Google Scholar
• ThompsonGRBarbirMDaviesDEfficacy criteria and cholesterol targets for LDL apheresisAtherosclerosis2010208231732119589528
   PubMed Web of Science ®Google Scholar
• PalcouxJBAtassi-DumontMLefevrePLow-density lipoprotein apheresis in children with familial hypercholesterolemia: follow-up to 21 yearsTher Apher Dial200812319520118503695
   PubMed Web of Science ®Google Scholar
• HudginsLKleinmanBScheuerAWhiteSGordonBRLong-term safety and efficacy of low-density lipoprotein apheresis in childhood for homozygous familial hypercholesterolemiaAm J Cardiol200810291199120418940291
   PubMed Web of Science ®Google Scholar
• ThompsonGRThe evidence-base for the efficacy of lipoprotein apheresis in combating cardiovascular diseaseAtheroscler Supp20131416770
   PubMed Web of Science ®Google Scholar
• StarzlTEBilheimerDWBahnsonHTHeart–liver transplantation in a patient with familial hypercholesterolemiaLancet198418391138213836145836
   PubMed Web of Science ®Google Scholar
• MalatackJJLiver transplantation as treatment for familial homozygous hypercholesterolemia: too early or too latePediatr Transplant201115212312521219559
   PubMed Web of Science ®Google Scholar
• MaioranaANobiliVCalandraSPreemptive liver transplantation in a child with familial hypercholesterolemiaPediatr Transplant2011152E25E2920846238
   PubMed Web of Science ®Google Scholar
• KüçükkartallarTYankolYKanmazTTopaloğluSAcarliKKalayogluMLiver transplantation as a treatment option for three siblings with homozygous familial hypercholesterolemiaPediatr Transplant201115328128421235710
   PubMed Web of Science ®Google Scholar
• KakaeiFNikeghbalianSKazemiKLiver transplantation for homozygous familial hypercholesterolemia: two case reportsTransplantation Proc200941729392941
   PubMed Web of Science ®Google Scholar
• HussainMMShiJDreizenPMicrosomal triglyceride transfer protein and its role in apoB-lipoprotein assemblyJ Lipid Res2003441223212518019
   PubMed Web of Science ®Google Scholar
• WetterauJRAggerbeckLPBoumaMEAbsence of microsomal triglyceride transfer protein in patients with abetalipoproteinemiaScience1992258508499910011439810
   PubMed Web of Science ®Google Scholar
• Berriot-VaroqueauxNAggerbeckLPSamson-BoumaMWetterauJRThe role of the microsomal triglyceride transfer protein in abetalipoproteinemiaAnnu Rev Nutr20002066369710940349
   PubMed Web of Science ®Google Scholar
• GlueckCJGartsidePSMelliesMJSteinerPMFamilial hypobeta-lipoproteinemia: studies in 13 kindredsTrans Assoc Am Physicians197790184203205980
   PubMedGoogle Scholar
• JamilHGordonDAEusticeDCAn inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cellsProc Natl Acad Sci U S A1996932111991119958876250
   PubMed Web of Science ®Google Scholar
• BakillahANayakNSaxenaUMedfordRMHussainMMDecreased secretion of ApoB follows inhibition of ApoB-MTP binding by a novel antagonistBiochemistry200039164892489910769147
   PubMed Web of Science ®Google Scholar
• KsanderGdeJesusRYuanADiaminoindanes as microsomal triglyceride transfer protein inhibitorsJ Med Chem200144264677468711741485
   PubMed Web of Science ®Google Scholar
• ChangGRuggeriRBHarwoodHJJrMicrosomal triglyceride transfer protein (MTP) inhibitors: discovery of clinically active inhibitors using high-throughput screening and parallel synthesis paradigmsCurr Opin Drug Discov Devel200254562570
   PubMedGoogle Scholar
• WetterauJRGreggREHarrityTWAn MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbitsScience199828253897517549784135
   PubMed Web of Science ®Google Scholar
• KitaTBrownMSWatanabeYGoldsteinJLDeficiency of low density lipoprotein receptors in liver and adrenal gland of the WHHL rabbit, an animal model of familial hypercholesterolemiaProc Natl Acad Sci U S A1981784226822726264472
   PubMed Web of Science ®Google Scholar
• ShiomiMItoTMTP inhibitor decreases plasma cholesterol levels in LDL receptor-deficient WHHL rabbits by lowering the VLDL secretionEur J Pharmacol2001431112713111716851
   PubMed Web of Science ®Google Scholar
• SamahaFFMcKenneyJBloedonLTSasielaWJRaderDJInhibition of micosomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemiaNatl Clin Pract Cardiovasc Med200858497505
   PubMedGoogle Scholar
• TemelRETangWMaYHepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibeJ Clin Invest200711771968197817571164
   PubMed Web of Science ®Google Scholar
• IkewakiKRaderDJZechLABrewerHBJrIn vivo metabolism of apolipoprotein A-I and E in patients with abetalipoproteinemia: implications for the roles of apolipoproteins B and E in HDL metabolismJ Lipid Res19943510180918197852858
   PubMed Web of Science ®Google Scholar
• CuchelMRaderDJMicrosomal transfer protein inhibition in humansCurr Opin Lipidol201324324625023594709
   PubMed Web of Science ®Google Scholar
• CuchelMBloedonLTSzaparyPOInhibition of microsomal triglyceride transfer protein in familial hypercholesterolemiaN Engl J Med2007356214815617215532
   PubMed Web of Science ®Google Scholar
• CuchelMMeagherEAdu Toit TheronHPhase 3 HoFH Lomitapide Study investigatorsEfficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 studyLancet20133819860404623122768
   PubMed Web of Science ®Google Scholar
• RaalFJLomitapide for homozygous familial hypercholesterolaemiaLancet201338198607823122767
   PubMed Web of Science ®Google Scholar
• SharpDBlindermanLCombsKACloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemiaNature1993365644165698361539
   PubMed Web of Science ®Google Scholar
• RobinsonJGManagement of familial hypercholesterolemia: a review of the recommendations from the National Lipid Association Expert Panel on Familial HypercholesterolemiaJ Manag Care Pharm201319213914923461430
   PubMed Web of Science ®Google Scholar
• SachaisBSKatzJRossJRaderDJLong-term effects of LDL apheresis in patients with severe hypercholesterolemiaJ Clin Apher200520425225515880364
   PubMed Web of Science ®Google Scholar
• MaraisADBlomDJRecent advances in the treatment of homozygous familial hypercholesterolaemiaCurr Opin Lipidol201324428829423839331
   PubMed Web of Science ®Google Scholar
• Aegerion Pharmaceuticals IncFDA approves Aegerion Pharmaceuticals’ JUXTAPID™ (lomitapide) capsules for homozygous familial hypercholesterolemia (HoFH) [press release]Cambridge, MAAegerion Pharmaceuticals Inc.2012 [Dec 24]. Available from: http://ir.aegerion.com/releasedetail.cfm?ReleaseID=728650Accessed February 17, 2013
   Google Scholar
• GoldbergACEmerging low-density lipoprotein therapies: Microsomal triglyceride transfer protein inhibitorsJ Clin Lipidol20137Suppl 3S16S2023642324
   PubMed Web of Science ®Google Scholar
• PlakogiannisRCioceLFisherEAUnderbergJAThe role of mipomersen therapy in the treatment of familial hypercholesterolemiaClin Investig (Lond)201221010331037
   Google Scholar
• SteinEAHonarpurNWassermanSMXuFScottRRaalFJEffect of the proprotein convertase subtilisin/kexin 9 monoclonal antibody, AMG 145, in homozygous familial hypercholesterolemiaCirculation2013128191281921132120
   Web of Science ®Google Scholar